MB
GTHX
MPM BioImpact’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-650,000
| Closed | -$3.53M | – | 34 |
|
|
2022
Q4 | $3.53M | Sell |
650,000
-206,798
| -24% | -$1.12M | 0.92% | 24 |
|
|
2022
Q3 | $10.7M | Hold |
856,798
| – | – | 2.53% | 13 |
|
|
2022
Q2 | $4.23M | Hold |
856,798
| – | – | 1.18% | 23 |
|
|
2022
Q1 | $6.51M | Hold |
856,798
| – | – | 1.75% | 16 |
|
|
2021
Q4 | $8.75M | Sell |
856,798
-3,704
| -0.4% | -$37.8K | 1.59% | 17 |
|
|
2021
Q3 | $11.5M | Buy |
860,502
+47,708
| +6% | +$640K | 1.79% | 14 |
|
|
2021
Q2 | $17.8M | Sell |
812,794
-115,000
| -12% | -$2.52M | 2.93% | 11 |
|
|
2021
Q1 | $22.3M | Sell |
927,794
-496,000
| -35% | -$11.9M | 2.8% | 9 |
|
|
2020
Q4 | $25.6M | Hold |
1,423,794
| – | – | 4.5% | 8 |
|
|
2020
Q3 | $16.4M | Hold |
1,423,794
| – | – | 3.96% | 9 |
|
|
2020
Q2 | $34.5M | Hold |
1,423,794
| – | – | 9.18% | 6 |
|
|
2020
Q1 | $15.7M | Hold |
1,423,794
| – | – | 9.58% | 4 |
|
|
2019
Q4 | $37.6M | Buy |
+1,423,794
| New | +$37.6M | 13.34% | 4 |
|